Cardiologists' use of percutaneous coronary interventions for stable coronary artery disease

被引:95
|
作者
Lin, Grace A.
Dudley, R. Adams
Redberg, Rita F.
机构
[1] Univ Calif San Francisco, Sch Med, Div Cardiol, San Francisco, CA 94143 USA
[2] Univ Calif San Francisco, Div Gen Internal Med, San Francisco, CA 94143 USA
[3] Univ Calif San Francisco, Inst Hlth Policy Studies, San Francisco, CA 94143 USA
关键词
D O I
10.1001/archinte.167.15.1604
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Background: Percutaneous coronary intervention (PCI) is commonly performed in patients with stable coronary artery disease, despite current evidence suggesting that such patients derive minimal benefit from the procedure. We sought to determine the influences on cardiologists' decision to perform elective PCI in patients with stable coronary artery disease. Methods: We conducted a qualitative study using 3 focus groups of interventional and noninterventional cardiologists in California. Participants discussed issues surrounding the decision to perform PCI using hypothetical case scenarios. We analyzed the data according to the principles of grounded theory. Results: Despite acknowledging data showing that PCI offers no reduction in the risk of death or myocardial infarction in patients with stable coronary artery disease, cardiologists generally believed that PCI would benefit such patients. Reasons given for performing PCI included belief the benefits of treating ischemia and the open artery hypothesis, especially with drug-eluting stents; potential regret for not intervening if a cardiac event could be averted; alleviation of patient anxiety; and medicolegal considerations. Participants believed that, in patients undergoing coronary angiography, an "oculostenotic reflex" prevailed and all significant amenable stenoses would receive intervention, even in asymptomatic patients. Conclusions: The widespread application of PCI in stable coronary artery disease for indications unsupported by evidence may reflect discordance between cardiologists' clinical knowledge and their beliefs about the benefits of PCI. Nonclinical factors appear to have substantial influence on physician decision making. Future studies should focus on the development of methods to help providers more fully incorporate clinical evidence into their medical decision making.
引用
收藏
页码:1604 / 1609
页数:6
相关论文
共 50 条
  • [41] Percutaneous coronary interventions for stable ischemic heart disease in Italy
    De Servi, Stefano
    Olivari, Zoran
    Crimi, Gabriele
    Marino, Marcello
    Alberti, Luca P.
    Tagliabue, Elena
    Leonardi, Sergio
    JOURNAL OF CARDIOVASCULAR MEDICINE, 2019, 20 (11) : 762 - 767
  • [42] Direct Oral Anticoagulants use in Patients with Stable Coronary Artery Disease, Acute Coronary Syndrome or Undergoing Percutaneous Coronary Intervention
    Sagris, Marios
    Theofilis, Panagiotis
    Papanikolaou, Angelos
    Antonopoulos, Alexios S.
    Tsioufis, Constantinos
    Tousoulis, Dimitris
    CURRENT PHARMACEUTICAL DESIGN, 2023, 29 (35) : 2787 - 2794
  • [43] Prophylactic Mechanical Circulatory Support Use in Elective Percutaneous Coronary Intervention for Patients With Stable Coronary Artery Disease
    Zeitouni, Michel
    Marquis-Gravel, Guillaume
    Smilowitz, Nathaniel R.
    Zakroysky, Pearl
    Wojdyla, Daniel M.
    Amit, Amin P.
    Rao, Sunil V.
    Wang, Tracy Y.
    CIRCULATION-CARDIOVASCULAR INTERVENTIONS, 2022, 15 (05) : 415 - 426
  • [44] Percutaneous peripheral interventions in patients with multivessel coronary artery disease
    Bartus, Stanislaw
    Siudak, Zbigniew
    Brzezinski, Michal
    Dziewierz, Artur
    Chyrchel, Michal
    Rakowski, Tomasz
    Dubiel, Jacek
    Dudek, Dariusz
    KARDIOLOGIA POLSKA, 2010, 68 (10) : 1115 - 1120
  • [45] Coronary Artery Bypass Graft Surgery and Percutaneous Coronary Interventions in Patients With Unprotected Left Main Coronary Artery Disease
    Zheng, Zhe
    Xu, Bo
    Zhang, Heng
    Guan, Changdong
    Xian, Ying
    Zhao, Yanyan
    Fan, Hongyang
    Yang, Yuejin
    Wang, Wei
    Gao, Runlin
    Hu, Shengshou
    JACC-CARDIOVASCULAR INTERVENTIONS, 2016, 9 (11) : 1102 - 1111
  • [46] Procedural Outcomes After Percutaneous Coronary Interventions in Focal and Diffuse Coronary Artery Disease
    Mizukami, Takuya
    Sonck, Jeroen
    Sakai, Koshiro
    Ko, Brian
    Maeng, Michael
    Otake, Hiromasa
    Koo, Bon-Kwon
    Nagumo, Sakura
    Norgaard, Bjarne L.
    Leipsic, Jonathon
    Shinke, Toshiro
    Munhoz, Daniel
    Mileva, Niya
    Belmonte, Marta
    Ohashi, Hirofumi
    Barbato, Emanuele
    Johnson, Nils P.
    De Bruyne, Bernard
    Collet, Carlos
    JOURNAL OF THE AMERICAN HEART ASSOCIATION, 2022, 11 (23):
  • [47] Depressive symptoms in patients with coronary artery disease after percutaneous coronary interventions (PCIs)
    Dudek, Dominika
    Dudek, Dariusz
    Siwek, Marcin
    Datka, Wojciech
    Rzeszutko, Lukasz
    Silczuk, Andrzej
    Zieba, Andrzej
    ARCHIVES OF PSYCHIATRY AND PSYCHOTHERAPY, 2007, 9 (03): : 63 - 70
  • [48] Percutaneous coronary interventions for coronary artery disease: the long and short of optimizing medical therapy
    Jaumdally, R
    Lip, GYH
    Varma, C
    INTERNATIONAL JOURNAL OF CLINICAL PRACTICE, 2005, 59 (09) : 1070 - 1081
  • [49] Effects of statin therapy on markers of inflammation and platelet activation following percutaneous coronary interventions in patients with stable coronary artery disease
    Azar, RR
    Sarkis, A
    Badaoui, G
    Kassab, R
    Neemtallah, R
    Kadri-Maalouf, Z
    Germanos, M
    CIRCULATION, 2004, 110 (17) : 614 - 614
  • [50] The Advances in Treatment for Coronary Artery Disease, Voices from Interventional Cardiologists at the Fortieth Year of Percutaneous Coronary Intervention
    Wu, Wen
    CURRENT PHARMACEUTICAL DESIGN, 2018, 24 (04) : 379 - 380